ABSTRACT
BACKGROUND: Stereoelectroencephalography (sEEG) is an increasingly popular surgical technique used clinically to study neural circuits involved in medication-refractory epilepsy, and it is concomitantly used in the scientific investigation of neural circuitry underlying behavior. METHODS: Using PRISMA guidelines, the U.S. National Library of Medicine at the National Institutes of Health PubMed database was queried for investigational or therapeutic applications of sEEG in human subjects. Abstracts were analyzed independently by 2 authors for inclusion or exclusion. RESULTS: The study search identified 752 articles, and after exclusion criteria were applied, 8 studies were selected for in-depth review. Among those 8 studies, 122 patients were included, with indications ranging from schizophrenia to Parkinson disease. All the included studies were single-institution case series representing level IV scientific evidence. CONCLUSIONS: sEEG is an important method in epilepsy surgery that could be applied to other neurologic and psychiatric diseases. Information from these studies could provide additional pathophysiologic information and lead to further development and refinement of neuromodulation therapies for such conditions.
Subject(s)
Brain/physiopathology , Brain/surgery , Electroencephalography/methods , Epilepsy/physiopathology , Epilepsy/surgery , Stereotaxic Techniques , Brain Mapping/methods , Brain Mapping/trends , Electroencephalography/trends , Epilepsy/diagnosis , Humans , Parkinson Disease/diagnosis , Parkinson Disease/physiopathology , Parkinson Disease/surgery , Psychosurgery/methods , Psychosurgery/trends , Schizophrenia/diagnosis , Schizophrenia/physiopathology , Schizophrenia/surgery , Stereotaxic Techniques/trendsABSTRACT
OBJECTIVE: Despite national guidelines supporting surgical referral in drug-resistant epilepsy, it is hypothesized that surgery is underutilized. We investigated the volumes of lobectomy/amygdalohippocampectomy surgeries over time and examined differences in outcomes between (1) high-volume (HV), middle-volume (MV), and low-volume (LV) hospitals and (2) Level 4 Centers versus non-Level 4 Centers. METHODS: The 2003-2014 National Inpatient Sample (the largest all-payer hospitalization database, representative of the US population) was utilized. Epilepsy was identified using a previously validated International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) case definition and surgeries using ICD-9-CM procedure codes. A hospital was considered a Level 4 Center if it performed intracranial electroencephalographic (EEG) monitoring. Tumor surgeries were excluded. Linear regression was used to perform trend tests. Weighted multivariate logistic regression was used to summarize association of surgery with outcomes. RESULTS: A total of 4,487 lobectomy/amygdalohippocampectomy surgeries were performed in children and adults with epilepsy. Lobectomy/amygdalohippocampectomy surgeries significantly decreased over time (slope: -0.24, P < .001). This declining surgical trend was greater for all resective/disconnective surgery (slope: -0.45, P < .001), and greatest when compared to all types of epilepsy surgery, for example, resection/disconnection/radiosurgery/laser interstitial thermal therapy/vagus nerve stimulation/deep brain stimulation/responsive neurostimulation/intracranial EEG (slope: -0.95, P < .001). LV compared to HV hospitals had higher odds of transfer to other facilities (13.60% vs 4.24%, odds ratio [OR] = 2.76, 95% confidence interval [CI] = 1.11-6.82). LV hospitals had higher odds of surgical complications versus MV (12.69% vs 6.80%, OR = 2.20, 95% CI = 1.01-5.09). HV hospitals incurred the least total charges. There were no differences in discharge status, adverse events, length of stay, or cost between Level 4 Centers versus non-Level 4 Centers. SIGNIFICANCE: Lobectomies/amygdalohippocampectomies are decreasing over time, suggesting ongoing underutilization. LV centers are associated with greater complication and transfer rates. Future studies are required to understand the reason for worse outcomes in LV centers and to determine whether a minimum number of surgeries must be performed to meet necessary standards.
Subject(s)
Amygdala/surgery , Anterior Temporal Lobectomy/trends , Hippocampus/surgery , Hospital Bed Capacity , Hospitalization/trends , Population Surveillance , Adolescent , Adult , Aged , Child , Child, Preschool , Drug Resistant Epilepsy/epidemiology , Drug Resistant Epilepsy/surgery , Female , Humans , Infant , Infant, Newborn , Length of Stay/trends , Male , Middle Aged , Psychosurgery/trends , Treatment Outcome , United States/epidemiology , Young AdultABSTRACT
Schizophrenia is a chronic and disabling psychiatric disease that can be refractory to conventional treatment. The present study aims to gather information about the circuitry related to schizophrenia to describe possible surgical targets, and to establish whether psychosurgery can be a safe and effective treatment option for refractory schizophrenia. A systematic review of the literature was conducted and reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. An electronic search was performed in the Pubmed and BVSalud databases using medical subject headings (MeSH) combined with Boolean operators. Out of the 724 studies retrieved, 13 were included in the review. Regarding leucotomy without a stereotactic approach, we found side effects such as irritability, nervous excitement, cases of disinhibition, and compromised normal social control. In other stereotactic procedures, there was some improvement, mainly regarding aggressiveness and positive symptoms; an anterior capsulotomy had an efficacy rate of 74% according to the Clinical Global Impression (CGI) rating scales. The only deep brain stimulation (DBS) case report found in our study described a significant improvement in the positive and negative symptoms. The use of a stereotactic approach enables psychosurgery to be a safe and effective treatment option in cases of refractory schizophrenia, improving the quality of life and the symptoms. Cognitive and negative symptoms remain a challenge in the treatment of schizophrenia, revealing that more targets in the circuitrymust be surgically explored. Furthermore,more clinical trials are needed to compare these many surgical techniques and targets, using a standard evaluation parameter. The results show that DBS has a promising future in the treatment of refractory schizophrenia.
Subject(s)
Psychosurgery/trends , Deep Brain Stimulation/adverse effects , Schizophrenia, Treatment-Resistant/surgery , Neurosurgery/trends , Psychosurgery/adverse effects , Stereotaxic Techniques , Postoperative Cognitive Complications , Schizophrenia, Treatment-Resistant/diagnosisABSTRACT
BACKGROUND: Thalamotomy is an endorsed treatment for medication-refractory tremor. It used to be the standard, but nowadays deep brain stimulation (DBS) has become the treatment option of choice. Nevertheless, DBS has the disadvantage of hardware failure, battery replacement, and frequent setting adjustment. Radiofrequency (RF) thalamotomy lacks these issues, is relatively inexpensive, and has a broad applicability in patients with significant comorbidity. Therefore, we analyzed the long-term patient-reported outcome of RF thalamotomy in a cohort of patients with an otherwise intractable tremor. METHODS: A single-center cohort of 27 consecutive patients with intractable tremor was assessed after unilateral RF thalamotomy. Over time, 4 patients had died because of non-related causes. In total, 21 patients responded to a telephone survey to assess their personal judgment on postoperative tremor severity, using a validated tremor scale, adverse events, recurrence, and patient satisfaction. The median time between surgery and telephone survey was 39 months (range 12-126). Seven patients had an additional analysis with postoperative imaging, video-assisted electromyography tremor registration, and a self-reported treatment effect (SRTE) assessment. RESULTS: Nineteen out of 21 patients (90.5%) reported absence or significant improvement of their tremor. The rating score (WHIGET/UPDRS-III) dropped significantly from a mean of 3.57 preoperatively to 1.05 postoperatively (p < 0.001). Eleven patients (52.4%) reported adverse events, but the majority (76.2%) did not consider the adverse events to be severe. SRTE assessment showed a direct postoperative effect of 89.6 of 100 points (SD 10.8), with a gradual decrease to 75.3 (SD 23.5) during follow-up. CONCLUSIONS: RF thalamotomy is a very effective long-term treatment for medication-refractory tremor and should therefore be considered in patients with a refractory unilateral tremor.
Subject(s)
Patient Reported Outcome Measures , Psychosurgery/methods , Radiofrequency Ablation/methods , Thalamus/surgery , Tremor/surgery , Adult , Aged , Aged, 80 and over , Cohort Studies , Electromyography/methods , Female , Follow-Up Studies , Humans , Male , Middle Aged , Patient Satisfaction , Psychosurgery/trends , Radiofrequency Ablation/trends , Thalamus/diagnostic imaging , Treatment Outcome , Tremor/diagnostic imagingABSTRACT
Understanding the natural history of and factors associated with pharmacoresistant epilepsy provides the foundation for formulating mechanistic hypotheses that can be evaluated to drive the development of novel treatments. This article reviews the modern definition of drug-resistant epilepsy, its prevalence and incidence, risk factors, hypothesized mechanisms, and the implication of recognizing pharmacoresistance in therapeutic strategies. This article is part of the special issue entitled 'New Epilepsy Therapies for the 21st Century - From Antiseizure Drugs to Prevention, Modification and Cure of Epilepsy'.
Subject(s)
Anticonvulsants/therapeutic use , Diet, Ketogenic/trends , Drug Resistant Epilepsy/epidemiology , Drug Resistant Epilepsy/therapy , Psychosurgery/trends , Vagus Nerve Stimulation/trends , Animals , Clinical Trials as Topic/methods , Diet, Ketogenic/methods , Drug Resistant Epilepsy/physiopathology , Humans , Implantable Neurostimulators/trends , Psychosurgery/methods , Treatment Outcome , Vagus Nerve Stimulation/methodsABSTRACT
OBJECTIVE: Anterior capsulotomy (AC) is sometimes used as a life-saving treatment for patients with treatment-refractory obsessive-compulsive disorder (Tr-OCD). Most of the previous studies have assessed only total symptoms and have concluded that AC is a safe and effective procedure. Few of these studies have focused on meticulously investigating the variety of results obtained from patients with different subtypes of OCD. This study reviewed the long-term effects of AC on patients with OCD and analyzed the dissimilarity between particular subtypes of the disease in order to determine which groups are more suited to surgical treatment. METHODS: For this retrospective evaluation, we selected 54 consecutive patients from a total of 63 people with Tr-OCD between 2005 and 2014 who had undergone AC by thermocoagulation at our department. Preoperative and follow-up assessments were conducted at multiple time points (before surgery and 1, 3, 6, 12, and 36 months after surgery). The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), Hamilton Depression Scale (HAMD), and Hamilton Anxiety Scale (HAMA) were used to quantify the symptoms of OCD. According to different elements (clinical manifestation, comorbidity, and whether a patient was more compulsive or more obsessive), we classified patients into various subtypes and analyzed the variation in symptom improvement and adverse effects. RESULTS: The mean Y-BOCS, HAMD, and HAMA scores were, respectively, 27.03, 23.30, and 21.46 preoperatively and 8.50, 7.07, and 7.42, respectively, at 36 months after surgery. Most patients (n = 43, 79.6%) were shown to have been at least partially responsive to surgical treatment at their long-term follow-up. Six patients demonstrated no obvious improvement (Y-BOCS score decreased by <35%), and 5 patients developed recurrences of their conditions. The following subtypes demonstrated better results: contamination/cleaning; obsessions/checking; compulsive behavior dominant; pure OCD; and OCD with Tourette's -syndrome. The subtypes of aggressive/sexual, obsessive thought dominant, compulsive behavior with obsessive thoughts, OCD comorbidity with bipolar disorder, OCD comorbid with severe depression, and OCD comorbid with psychiatric symptoms showed good outcomes. However, surgery was ineffective for patients with the subtypes of symmetry/ordering, hoarding, pure obsessive thoughts, and OCD with obsessive slowness. CONCLUSIONS: AC is effective in reducing symptoms of OCD. By comparing differently classified follow-up results, we found that patients with most subtypes/dimensions of OCD showed good outcomes. How-ever, patients categorized into the OCD subtypes of pure -obsessive thoughts, symmetry/ordering, hoarding, OCD with obsessive slowness, and OCD comorbid with psychiatric symptoms should take into account these results before undergoing AC.
Subject(s)
Obsessive-Compulsive Disorder/diagnostic imaging , Obsessive-Compulsive Disorder/surgery , Psychosurgery/methods , Adolescent , Adult , Cognition/physiology , Female , Follow-Up Studies , Humans , Male , Middle Aged , Obsessive-Compulsive Disorder/psychology , Psychosurgery/trends , Retrospective Studies , Time Factors , Treatment Outcome , Young AdultABSTRACT
OBJECTIVE: To test the hypothesis that transcranial magnetic resonance-guided focused ultrasound (tcMRgFUS) thalamotomy is effective, durable, and safe for patients with medication-refractory essential tremor (ET), we assessed clinical outcomes at 3-year follow-up of a controlled multicenter prospective trial. METHODS: Outcomes were based on the Clinical Rating Scale for Tremor, including hand combined tremor-motor (scale of 0-32), functional disability (scale of 0-32), and postural tremor (scale of 0-4) scores, and total scores from the Quality of Life in Essential Tremor Questionnaire (scale of 0-100). Scores at 36 months were compared with baseline and at 6 months after treatment to assess for efficacy and durability. Adverse events were also reported. RESULTS: Measured scores remained improved from baseline to 36 months (all p < 0.0001). Range of improvement from baseline was 38%-50% in hand tremor, 43%-56% in disability, 50%-75% in postural tremor, and 27%-42% in quality of life. When compared to scores at 6 months, median scores increased for hand tremor (95% confidence interval [CI] 0-2, p = 0.0098) and disability (95% CI 1-4, p = 0.0001). During the third follow-up year, all previously noted adverse events remained mild or moderate, none worsened, 2 resolved, and no new adverse events occurred. CONCLUSIONS: Results at 3 years after unilateral tcMRgFUS thalamotomy for ET show continued benefit, and no progressive or delayed complications. Patients may experience mild degradation in some treatment metrics by 3 years, though improvement from baseline remains significant. CLINICALTRIALSGOV IDENTIFIER: NCT01827904. CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that for patients with severe ET, unilateral tcMRgFUS thalamotomy provides durable benefit after 3 years.
Subject(s)
Essential Tremor/diagnosis , Essential Tremor/surgery , Psychosurgery/methods , Thalamus/surgery , Ultrasonic Therapy/methods , Aged , Aged, 80 and over , Cohort Studies , Cross-Over Studies , Essential Tremor/physiopathology , Female , Follow-Up Studies , Humans , Male , Middle Aged , Prospective Studies , Psychosurgery/trends , Single-Blind Method , Surveys and Questionnaires , Thalamus/physiology , Time Factors , Ultrasonic Therapy/trendsABSTRACT
Selective laser amygdalohippocampotomy (SLAH) is a minimally invasive surgical treatment for medial temporal lobe epilepsy. Visual field deficits (VFDs) are a significant potential complication. The objective of this study was to determine the relationship between VFDs and potential mechanisms of injury to the optic radiations and lateral geniculate nucleus. We performed a retrospective cross-sectional analysis of 3 patients (5.2%) who developed persistent VFDs after SLAH within our larger series (n = 58), 15 healthy individuals and 10 SLAH patients without visual complications. Diffusion tractography was used to evaluate laser catheter penetration of the optic radiations. Using a complementary approach, we evaluated evidence for focal microstructural tissue damage within the optic radiations and lateral geniculate nucleus. Overablation and potential heat radiation were assessed by quantifying ablation and choroidal fissure CSF volumes as well as energy deposited during SLAH.SLAH treatment parameters did not distinguish VFD patients. Atypically high overlap between the laser catheter and optic radiations was found in 1/3 VFD patients and was accompanied by focal reductions in fractional anisotropy where the catheter entered the lateral occipital white matter. Surprisingly, lateral geniculate tissue diffusivity was abnormal following, but also preceding, SLAH in patients who subsequently developed a VFD (all p = 0.005).In our series, vision-related complications following SLAH, which appear to occur less frequently than following open temporal lobe -surgery, were not directly explained by SLAH treatment parameters. Instead, our data suggest that variations in lateral geniculate structure may influence susceptibility to indirect heat injury from transoccipital SLAH.
Subject(s)
Amygdala/surgery , Hippocampus/surgery , Laser Therapy/adverse effects , Postoperative Complications/etiology , Stereotaxic Techniques/adverse effects , Vision Disorders/etiology , Adolescent , Adult , Aged , Amygdala/diagnostic imaging , Cross-Sectional Studies , Epilepsy, Temporal Lobe/diagnostic imaging , Epilepsy, Temporal Lobe/surgery , Female , Follow-Up Studies , Hippocampus/diagnostic imaging , Humans , Laser Therapy/trends , Male , Middle Aged , Postoperative Complications/diagnostic imaging , Psychosurgery/adverse effects , Psychosurgery/trends , Retrospective Studies , Risk Factors , Stereotaxic Techniques/trends , Vision Disorders/diagnostic imaging , Visual Fields/physiology , Young AdultABSTRACT
The last two decades have seen a re-emergence of surgery for intractable psychiatric disease, in large part due to increased use of deep brain stimulation. The development of more precise, image-guided, less invasive interventions has improved the safety of these procedures, even though the relative merits of modulation at various targets remain under investigation. With an increase in the number and type of interventions for modulating mood/anxiety circuits, the need for biomarkers to guide surgeries and predict treatment response is as critical as ever. Electroencephalography (EEG) has a long history in clinical neurology, cognitive neuroscience, and functional neurosurgery, but has limited prior usage in psychiatric surgery. MEDLINE, Embase, and Psyc-INFO searches on the use of EEG in guiding psychiatric surgery yielded 611 articles, which were screened for relevance and quality. We synthesized three important themes. First, considerable evidence supports EEG as a biomarker for response to various surgical and non-surgical therapies, but large-scale investigations are lacking. Second, intraoperative EEG is likely more valuable than surface EEG for guiding target selection, but comes at the cost of greater invasiveness. Finally, EEG may be a promising tool for objective functional feedback in developing "closed-loop" psychosurgeries, but more systematic investigations are required.
Subject(s)
Electroencephalography/methods , Intraoperative Neurophysiological Monitoring/methods , Mental Disorders/surgery , Psychosurgery/methods , Deep Brain Stimulation/methods , Deep Brain Stimulation/trends , Electroencephalography/trends , Forecasting , Humans , Intraoperative Neurophysiological Monitoring/trends , Mental Disorders/diagnosis , Mental Disorders/psychology , Neurosurgical Procedures/methods , Neurosurgical Procedures/trends , Psychosurgery/trendsABSTRACT
Thalamotomy is an established treatment for medically refractory tremor. Major complications of thalamotomy include cognitive disturbance, paralysis, dysphagia, sensory loss, and speech disturbance. Hemiballism is a rare complication after thalamotomy. We herein present a 74-year-old female patient who developed choreo-ballistic movement after thalamotomy. She was diagnosed with Lewy body dementia at the age of 70â¯years and exhibited worsening bilateral hand tremor. Her tremor was severe and pharmacoresistant. Left thalamotomy was planned with the trajectory passing through the ventralis intermedius (VIM) nucleus to the posterior subthalamic area (PSA). The right VIM nucleus and PSA were both coagulated with one trajectory, resulting in the immediate amelioration of right hand tremor. However, four days after surgery, choreo-ballistic movement appeared in the right leg and persisted for six months. Furthermore, tremor recurred after one month. Postoperative MRI showed a small coagulated lesion in the subthalamic nucleus. Although choreo-ballistic movement is a rare complication, it needs to be considered, particularly in patients in which the inferior border of the VIM nucleus is targeted.
Subject(s)
Chorea/etiology , Lewy Body Disease/surgery , Postoperative Complications/etiology , Psychosurgery/adverse effects , Thalamus/surgery , Aged , Chorea/diagnostic imaging , Chorea/physiopathology , Female , Hand/physiopathology , Humans , Lewy Body Disease/diagnostic imaging , Postoperative Complications/diagnostic imaging , Psychosurgery/trends , Thalamus/diagnostic imagingABSTRACT
In order to shed light on the first application of human functional stereotactic neurosurgery, whether it was in the realm of movement disorders, as has been claimed repeatedly, or in the realm of psychiatry, a review of the original scholarly literature was conducted. Tracking and scrutinising original publications by Spiegel and Wycis, the pioneers of human stereotactic neurosurgery, it was found that its origin and the very incentive for its development and first clinical use were to avoid the side effects of frontal leucotomy. The first applications of functional stereotactic neurosurgery were in performing dorsomedial thalamotomies in psychiatric patients; it was only later that the stereotactic technique was applied in patients with chronic pain, movement disorders and epilepsy. Spiegel and Wycis' first functional stereotactic operations were for obsessive-compulsive disorder, schizophrenia, and other psychiatric conditions.
Subject(s)
Nervous System Diseases/surgery , Neurosurgery/trends , Stereotaxic Techniques/trends , Chronic Pain/diagnostic imaging , Chronic Pain/surgery , Epilepsy/diagnostic imaging , Epilepsy/surgery , Humans , Movement Disorders/diagnostic imaging , Movement Disorders/surgery , Nervous System Diseases/diagnostic imaging , Neurosurgery/methods , Obsessive-Compulsive Disorder/diagnostic imaging , Obsessive-Compulsive Disorder/surgery , Psychosurgery/methods , Psychosurgery/trendsABSTRACT
PURPOSE: The purpose of this study was to report long-term seizure outcome in patients who underwent frontal lobe epilepsy (FLE) surgery. METHOD: This retrospective study included 44 consecutive subjects who underwent resective surgery for intractable FLE at IRCCS NEUROMED (period 2001-2014), followed up for at least 2â¯years (mean: 8.7â¯years). All patients underwent noninvasive presurgical evaluation and/or invasive electroencephalography (EEG) monitoring when nonconcordant data were obtained or epileptogenic zone was hypothesized to be close to the eloquent cortex. Electroclinical, neuroimaging, surgical data, and histology were compared to seizure outcome. RESULTS: Mean epilepsy duration was 19â¯years; mean age at surgery was 31.6â¯years. Preoperative magnetic resonance imaging (MRI) showed a frontal lesion in 86.4 % of cases. Scalp video-electroencephalography (VEEG) monitoring detected a focal ictal onset in 90% of cases. Twenty-seven patients (61.4%) underwent invasive recordings. Resections involved dorsolateral (47.7%), medial (9%), orbital (13.6%), and rolandic (13.6%) region. Lobectomy within functional boundaries was performed in the remaining 7 cases (16%). Transient and permanent neurological deficits were observed in 2 and 3 cases, respectively. Histology revealed focal cortical dysplasia (45.5%), World Health Organization (WHO) I-II grade tumors (15.9%), gliosis (22.7%), vascular malformations (4.5%), Rasmussen encephalitis (6.8%), and normal tissue (4.5%). At last observation 68.1% of patients were in Engel's class I, 11.4% in class II, 9% in class III, and 11.4% in class IV. A favorable outcome was associated with focal ictal scalp EEG onset (pâ¯=â¯0.0357). CONCLUSION: Surgery is a safe treatment option in drug-resistant FLE with a satisfying long-term outcome. These data highlight the importance of an appropriate selection of potential surgical candidates.
Subject(s)
Electroencephalography/trends , Epilepsy, Frontal Lobe/diagnostic imaging , Epilepsy, Frontal Lobe/surgery , Seizures/diagnostic imaging , Seizures/surgery , Adolescent , Adult , Cerebral Cortex/diagnostic imaging , Cerebral Cortex/physiopathology , Child , Electroencephalography/methods , Epilepsy, Frontal Lobe/physiopathology , Female , Follow-Up Studies , Humans , Magnetic Resonance Imaging/methods , Magnetic Resonance Imaging/trends , Male , Middle Aged , Psychosurgery/methods , Psychosurgery/trends , Retrospective Studies , Seizures/physiopathology , Treatment Outcome , Young AdultABSTRACT
BACKGROUND: Surgical site infections (SSIs) after spine and brain surgery present a major burden to patients and hospitals by increasing morbidity, mortality, and healthcare costs. OBJECTIVE: To review available literature investigating the role of intrawound powdered vancomycin against SSIs after neurosurgical operations. METHODS: All randomized and observational English language studies of intrawound powdered vancomycin use in spinal and cranial surgery were included and analyzed using random-effects modeling. RESULTS: In spine surgery (25 studies with 16 369 patients), patients in the vancomycin group had a significantly lower risk for any SSI (odds ratio [OR]: 0.41; 95% confidence interval [CI]: 0.30-0.57; P < .001; I2 = 47%). However, when separate analyses were conducted for superficial and deep SSIs, a significant difference was found only for deep (OR: 0.31; 95% CI: 0.22-0.45; P < .001; I2 = 29%). Subgroup analyses for different vancomycin powder dosages (1 g vs 2 g vs composite dose) did not point to any dose-related effect of vancomycin. In cranial surgery (6 studies with 1777 patients), use of vancomycin was associated with a significantly lower risk for SSIs (OR: 0.33; 95% CI: 0.18-0.60; P = .0003; I2 = 45%). In meta-regression analysis, trial-level variability of diabetes had no influence on the association of vancomycin powder use with SSIs. CONCLUSION: Use of vancomycin powder in spinal and cranial surgery might be protective against SSIs, especially against deep SSIs. No dose-related effect of vancomycin powder was identified. However, caution is needed in the clinical interpretation of these results, owing to the observational design of the included studies in this meta-analysis.
Subject(s)
Anti-Bacterial Agents/administration & dosage , Neurosurgical Procedures/adverse effects , Surgical Wound Infection/prevention & control , Vancomycin/administration & dosage , Antibiotic Prophylaxis/methods , Humans , Neurosurgical Procedures/trends , Observational Studies as Topic/methods , Powders , Psychosurgery/adverse effects , Psychosurgery/trends , Randomized Controlled Trials as Topic/methods , Spine/surgery , Stereotaxic Techniques/adverse effects , Stereotaxic Techniques/trends , Surgical Wound Infection/drug therapy , Surgical Wound Infection/etiologyABSTRACT
Following the rise and fall of lobotomy, a majority of U.S. states took legislative aim at psychosurgical procedures. This article canvasses, organizes, and analyzes the existing body of United States statutes and regulations mentioning psychosurgery. Many states regulate psychosurgery without defining the term; existing definitions are imprecise, but many would arguably apply to contemporary procedures like deep brain stimulation. Common to many states are restrictions on surrogate consent to psychosurgery, codifications of patients' consent or refusal rights, and situation-specific bans on the practice targeting certain contexts of vulnerability. Many states have only a handful of scattered laws bearing on psychosurgery, but a few have wide-ranging and well-integrated regulatory regimes. In reviewing these laws we perceive much room for harmonization and modernization. Greater consistency in protecting vulnerable persons from troubling uses of psychosurgery is achievable even alongside an effort to remove undue legal obstacles impeding patient access to potentially therapeutic procedures. Our hope in surveying current psychosurgery law is to inaugurate a conversation on how best to shape its future.
Subject(s)
Informed Consent/legislation & jurisprudence , Legislation as Topic , Patient Rights/legislation & jurisprudence , Psychosurgery/legislation & jurisprudence , Psychosurgery/trends , State Government , Treatment Refusal/legislation & jurisprudence , Civil Rights , Humans , Institutionalization/legislation & jurisprudence , United States , Vulnerable Populations/legislation & jurisprudenceABSTRACT
OBJECTIVE: The objective of this research was to evaluate a cohort of children with both autism spectrum disorder (ASD) and drug-resistant epilepsy (DRE) after epilepsy surgery to determine predictors of best outcome. METHODS: Retrospective chart review was done for 29 children ages 2 to 18â¯years with ASD and DRE who had neurosurgical intervention for seizure management over 15â¯years at one institution. All subjects had at least 1â¯year of follow-up. Data abstraction included demographic information, seizure diagnosis, treatment, investigations, surgical intervention, neuropsychological assessment, and outcome. Statistical analysis software (SAS) was used for statistical analysis. Engel classification was used to assess seizure outcome. RESULTS: Fifteen subjects had resective surgery. Fourteen had palliative surgery with vagal nerve stimulator (VNS) insertion (13) and corpus callosotomy (1). Of the 29 subjects, 35% had class I outcome (all in the resective group). When combining all subjects (resective and palliative), 66% of subjects benefited with class I-III outcomes. In the total cohort, age at time of surgery was significant, with class I outcome more frequently seen in the younger age group when compared with classes II-IV (pâ¯=â¯0.01). CONCLUSION: A subset of children with ASD can benefit from resective surgery, and for those who are not candidates, a VNS can offer significant improvements in seizure control.
Subject(s)
Autism Spectrum Disorder/epidemiology , Autism Spectrum Disorder/surgery , Drug Resistant Epilepsy/epidemiology , Drug Resistant Epilepsy/surgery , Neurosurgical Procedures/methods , Vagus Nerve Stimulation/methods , Adolescent , Autism Spectrum Disorder/diagnostic imaging , Child , Child, Preschool , Cohort Studies , Drug Resistant Epilepsy/diagnostic imaging , Female , Follow-Up Studies , Humans , Male , Neurosurgical Procedures/trends , Psychosurgery/methods , Psychosurgery/trends , Retrospective Studies , Treatment Outcome , Vagus Nerve Stimulation/trendsABSTRACT
OBJECTIVE: The International League Against Epilepsy (ILAE) proposed a classification system for hippocampal sclerosis (HS) based on location and extent of hippocampal neuron loss. The literature debates the usefulness of this classification system when studying memory in people with temporal lobe epilepsy (TLE) and determining memory outcome after temporal lobe resection (TLR). This study further explores the relationship between HS ILAE subtypes and episodic memory performance in patients with TLE and examines memory outcomes after TLR. METHODS: This retrospective study identified 213 patients with TLE who underwent TLR and had histopathological evidence of HS (HS ILAE type 1a = 92; type 1b = 103; type 2 = 18). Patients completed the Wechsler Memory Scale-3rd Edition prior to surgery, and 78% of patients had postoperative scores available. Linear regressions examined differences in preoperative memory scores as a function of pathology classification, controlling for potential confounders. Fisher's exact tests were used to compare pathology subtypes on the magnitude of preoperative memory impairment and the proportion of patients who experienced clinically meaningful postoperative memory decline. RESULTS: Individuals with HS ILAE type 2 demonstrated better preoperative verbal memory performance than patients with HS ILAE type 1; however, individual data revealed verbal and visual episodic memory impairments in many patients with HS ILAE type 2. The base rate of postoperative memory decline was similar among all 3 pathology groups. SIGNIFICANCE: This is the largest reported overall sample and the largest subset of patients with HS ILAE type 2. Group data suggest that patients with HS ILAE type 2 perform better on preoperative memory measures, but individually there were no differences in the magnitude of memory impairment. Following surgery, there were no statistically significant differences between groups in the proportion of patients who declined. Future research should focus on quantitative measurements of hippocampal neuronal loss, and multicenter collaboration is encouraged.
Subject(s)
Anterior Temporal Lobectomy/trends , Epilepsy, Temporal Lobe/diagnosis , Epilepsy, Temporal Lobe/surgery , Hippocampus/pathology , Memory Disorders/diagnosis , Memory, Episodic , Adolescent , Adult , Aged , Anterior Temporal Lobectomy/adverse effects , Cohort Studies , Female , Humans , Male , Memory Disorders/etiology , Middle Aged , Psychosurgery/adverse effects , Psychosurgery/trends , Retrospective Studies , Sclerosis , Young AdultABSTRACT
Before the advent of levodopa, pallidotomy was initially the most effective treatment for Parkinson disease, but it was soon superseded by thalamotomy. It is widely unknown that, similar to Leksell, 2 neurologists from Göttingen, Orthner and Roeder, perpetuated pallidotomy against the mainstream of their time. Postmortem studies demonstrated that true posterior and ventral pallidoansotomy sparing the overwhelming mass of the pallidum was accomplished. This was due to a unique and individually tailored stereotactic technique even allowing bilateral staged pallidotomies. In 1962, the long-term effects (3-year follow-up on average) of the first 18 out of 36 patients with staged bilateral pallidotomies were reported in great detail. Meticulous descriptions of each case indicate long-term improvements in parkinsonian rigidity and associated pain, as well as posture, gait, and akinesia (e.g., improved repetitive movements and arm swinging). Alleviation of tremor was found to require larger lesions than needed for suppression of rigidity. No improvement in speech, drooling, or seborrhea was observed. By 1962, the team had operated 13 patients with postencephalitic oculogyric crises with remarkable results (mean follow-up: 5 years). They also described alleviation of nonparkinsonian hyperkinetic disorders (e.g., hemiballism and chorea) with pallidotomy. The reported rates for surgical mortality and other complications had been remarkably low, even if compared to those reported after the revival of pallidotomy by Laitinen in the post-levodopa era. This applies also to bilateral pallidotomy performed with a positive risk-benefit ratio that has remained unparalleled to date. The intricate history of pallidotomy for movement disorders is incomplete without an appreciation of the achievements of the Göttingen group.
Subject(s)
Globus Pallidus/surgery , Levodopa/therapeutic use , Movement Disorders/surgery , Pallidotomy/methods , Stereotaxic Techniques , Adult , Aged , Chorea/diagnostic imaging , Chorea/surgery , Diagnosis , Dyskinesias/diagnostic imaging , Dyskinesias/surgery , Female , Globus Pallidus/diagnostic imaging , Humans , Imaging, Three-Dimensional/methods , Male , Middle Aged , Movement Disorders/diagnostic imaging , Pallidotomy/trends , Parkinson Disease/diagnostic imaging , Parkinson Disease/surgery , Psychosurgery/methods , Psychosurgery/trends , Stereotaxic Techniques/trends , Thalamus/surgery , Treatment Outcome , Tremor/diagnostic imaging , Tremor/surgeryABSTRACT
Neurosurgery for the treatment of psychological disorders has a checkered history in the United States. Prior to the advent of antipsychotic medications, individuals with severe mental illness were institutionalized and subjected to extreme therapies in an attempt to palliate their symptoms. Psychiatrist Walter Freeman first introduced psychosurgery, in the form of frontal lobotomy, as an intervention that could offer some hope to those patients in whom all other treatments had failed. Since that time, however, the use of psychosurgery in the United States has waxed and waned significantly, though literature describing its use is relatively sparse. In an effort to contribute to a better understanding of the evolution of psychosurgery, the authors describe the history of psychosurgery in the state of Iowa and particularly at the University of Iowa Department of Neurosurgery. An interesting aspect of psychosurgery at the University of Iowa is that these procedures have been nearly continuously active since Freeman introduced the lobotomy in the 1930s. Frontal lobotomies and transorbital leukotomies were performed by physicians in the state mental health institutions as well as by neurosurgeons at the University of Iowa Hospitals and Clinics (formerly known as the State University of Iowa Hospital). Though the early technique of frontal lobotomy quickly fell out of favor, the use of neurosurgery to treat select cases of intractable mental illness persisted as a collaborative treatment effort between psychiatrists and neurosurgeons at Iowa. Frontal lobotomies gave way to more targeted lesions such as anterior cingulotomies and to neuromodulation through deep brain stimulation. As knowledge of brain circuits and the pathophysiology underlying mental illness continues to grow, surgical intervention for psychiatric pathologies is likely to persist as a viable treatment option for select patients at the University of Iowa and in the larger medical community.
Subject(s)
Hospitals, Psychiatric/history , Mental Disorders/history , Neurosurgeons/history , Psychosurgery/history , History, 20th Century , History, 21st Century , Hospitals, Psychiatric/trends , Humans , Iowa/epidemiology , Mental Disorders/epidemiology , Mental Disorders/surgery , Neurosurgeons/trends , Psychosurgery/trends , Universities/history , Universities/trendsABSTRACT
BACKGROUND: There is an urgent need to develop safe and effective treatments for patients with treatment-resistant depression (TRD). Several neurosurgical procedures have been developed to treat the dysfunctional brain circuits implicated in major depression. OBJECTIVES: This review describes the most common ablative procedures used to treat major depressive disorder: anterior cingulotomy, subcaudate tractotomy, limbic leucotomy, and anterior capsulotomy. The efficacy and safety of each are discussed and compared with other current and emerging modalities, including deep brain stimulation (DBS) and MR-guided focused ultrasound (MRgFUS). METHODS: The PubMed and MEDLINE electronic databases were used in this study, through July 2016. Keywords, including "treatment resistant depression," and "ablative neurosurgery," etc. were used to generate reference hits. RESULTS: Approximately a third to half of patients who underwent ablative procedures achieved a treatment response and/or remission. The efficacy and safety profiles corresponding to both ablative procedures and DBS were very similar. CONCLUSIONS: The longitudinal experience with ablative procedures shows that there remains an important role for accurate, discrete lesions in disrupting affective circuitry in the treatment of TRD. New modalities, such as MRgFUS, have the potential to further improve the accuracy of ablative procedures, while enhancing safety by obviating the need for open brain surgery.